LHX2 and nasopharyngeal carcinoma: For instance, the overexpression of LHX2 promotes the development of chronic myeloid leukemia [26], pancreatic ductal carcinoma [27], nasopharyngeal carcinoma [28], and non-small-cell lung cancer [29].